Hatice Yücel

870 citations
6 papers · 618 · 1 hit paper · h-index 5

Impact in

  • Oncology top 10%
    • PARP inhibition in cancer therapy
    • DNA Repair Mechanisms
    • CRISPR and Genetic Engineering
    • Epigenetics and DNA Methylation
    • Genomics and Chromatin Dynamics

Papers in

    • DNA Repair Mechanisms 3
    • CRISPR and Genetic Engineering 2
    • Genomics and Phylogenetic Studies 1
    • Epigenetics and DNA Methylation 1
    • Genomics and Chromatin Dynamics 1
    • Gene expression and cancer classification 1
    • PARP inhibition in cancer therapy 3

Hatice Yücel

5 papers receiving 616 citations

Hatice Yücel's Hit Papers

A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors 2021 · 232 citations
2320+1+3Years since publication50100150200

Peers

Hatice Yücel
Comparison fields: 5 of 45
  • Oncology 370
  • Molecular Biology 492
  • Cancer Research 58
  • Reproductive Medicine 30
  • Genetics 80
Replace Ewa Gogola with:
Ewa Gogola Netherlands
Connor S. Clairmont United States
Camille Gelot France
Niraj Joshi Canada
Kamakoti P. Bhat United States
Benjamin Primack United States
Dongxue Su China
Muthana Al Abo United States
Ute Boon Netherlands
Tanay Thakar United States
Hatice Yücel relative to Ewa Gogola Netherlands Ewa Gogola's profile →
Citations per field
00.5×1.5×
Ewa Gogola · 1×
Citations per year

Countries citing papers authored by Hatice Yücel

Since Specialization
Citations

This map shows the geographic impact of Hatice Yücel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatice Yücel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatice Yücel more than expected).

Fields of papers citing papers by Hatice Yücel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hatice Yücel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatice Yücel. The network helps show where Hatice Yücel may publish in the future.

Co-authors

The 25 scholars most cited alongside Hatice Yücel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hatice Yücel Line = papers co-authored together Hatice Yücel links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1 2017263
2
A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors
Hit paper breakdown →
2021232
3 2016104
4 201713
5 20256
6 20250

About Hatice Yücel

Hatice Yücel is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 6 papers that have together received 618 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (3 papers), PARP inhibition in cancer therapy (3 papers), CRISPR and Genetic Engineering (2 papers), Genomics and Phylogenetic Studies (1 paper), Epigenetics and DNA Methylation (1 paper), Genomics and Chromatin Dynamics (1 paper), Gene expression and cancer classification (1 paper) and Radiation Therapy and Dosimetry (1 paper). The work is most often cited by research in Oncology (370 citations), Molecular Biology (492 citations), Cancer Research (58 citations), Reproductive Medicine (30 citations) and Genetics (80 citations). Hatice Yücel has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include Raphaël Ceccaldi, Alan D. D’Andrea, Jos Jonkers, Marieke van de Ven, Sven Rottenberg, Beatrice Rondinelli, Panagiotis A. Konstantinopoulos, Ewa Gogola, Alexandra A. Duarte and Constantia Pantelidou. Their work appears in journals such as Nature Cancer, Oncotarget, Nature Cell Biology, Molecular Cell and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact